Product Information
GRANISETRON HCL 1 MG TABLET is a generic product labeled by Bionpharma Inc., priced at $1.3050 per EA under NDC 69452035092. Its NADAC has been published 165 times since Aug 9, 2023.
FDA first approved this application on Feb 13, 2008. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
1 mg/1
Manufacturer
Bionpharma Inc.NDC
69452035092
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
GRANISETRON HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA078678FDA Approved
2/13/2008
TE Code
AB
On Market Since
2/28/2022
Pharmacological Classes
Price Statistics
The NADAC for GRANISETRON HCL 1 MG TABLET has been published 165 times since Aug 9, 2023, and over the history we have for it it has declined 41.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.3050 per EA |
|---|---|
| All-time high | $2.3497 (Mar 13, 2024) |
| All-time low | $1.0638 (Jun 19, 2024) |
| 52-week high | $1.6179 |
| 52-week low | $1.0722 |
| Median price | $1.4268 |
| Average price | $1.4722 |
| Largest weekly change | +42.5% (Feb 21, 2024) |
| Weeks tracked | 165 |
| Tracking since | Aug 9, 2023 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Bionpharma Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Granisetron Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Serotonin-3 Receptor Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of GRANISETRON HCL 1 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for GRANISETRON HCL 1 MG TABLET, manufactured by Bionpharma Inc., is $1.3050 per EA (NDC 69452035092), effective Sep 30, 2026.
How has the price of GRANISETRON HCL 1 MG TABLET changed over time?
Over the history we have for it, the NADAC for GRANISETRON HCL 1 MG TABLET has declined 41.5%. It has been tracked across 165 weekly CMS publications since Aug 9, 2023.
What are the highest and lowest recorded NADAC prices for GRANISETRON HCL 1 MG TABLET?
Since Aug 9, 2023, the NADAC for GRANISETRON HCL 1 MG TABLET has ranged from a low of $1.0638 (Jun 19, 2024) to a high of $2.3497 (Mar 13, 2024), with a median of $1.4268 per EA.
Are there cheaper alternatives to GRANISETRON HCL 1 MG TABLET?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as GRANISETRON HCL 1 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures GRANISETRON HCL 1 MG TABLET?
GRANISETRON HCL 1 MG TABLET (NDC 69452035092) is labeled by Bionpharma Inc., and CMS classifies it as a generic product.